Its awefully quiet on the BDA thread, has everyone sold out during the retracement.
I would have thought that todays update was exceptional and commercial in nature with the board focussing on building shareholder wealth long term
Ann: Bod Achieves Word First in Phase 1 Clinical Trial, page-5
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable